arrow-left-endarrow-right-end

News & Updates

The Latest on Internet Pharmacies, Supplements, Designer Drugs,
and Other High-Risk Merchants

Filter By:

As Coronavirus Spreads, So Do Fake, Unapproved, and Ineffective Test Kits

LegitScript has been proactively monitoring the online space in response to the outbreak of the virus SARS-CoV-2, which causes COVID-19, and has identified an increasing trend in the marketing of coronavirus-related products that present an elevated risk to consumers, payment service providers, and e-commerce platforms. In particular, the severe shortage of diagnostic kits to test…

Continue Reading ›

What’s Fishy About Merchants Selling Fish Antibiotics?

In an attempt to source cheaper healthcare alternatives, some consumers have turned to risky behaviors, including medicating themselves with animal drugs. One type of product sold online that has high risk for this kind of misuse is fish antibiotics. Given that fish and humans share many of the same medicines (e.g., amoxicillin, penicillin, tetracycline, and…

Continue Reading ›

Don’t Get Burned By Merchants Selling Ear Candles

Ear candling, also referred to as “coning,” is a popular practice believed to draw wax and other impurities out of the ear. Despite their widespread availability, these products are unapproved medical devices that can leave both consumers and payment service providers burned. Read on to find out what these products are and the regulatory framework…

Continue Reading ›

Why Are Supplement Ingredient Names So Confusing?

Have you ever heard of 1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol or 4-[2-(dimethylamino)ethyl]phenol? Probably not. How about higenamine or hordenine? That may be more likely, but did you know that 1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol and higenamine are actually the same ingredient? The same is true for 4-[2-(dimethylamino)ethyl]phenol and hordenine.  Ingredient names can be confusing because manufacturers don’t always follow guidelines set by the…

Continue Reading ›

New Supplement Website Certification Program Helps Sellers Reduce Advertising and E-commerce Disruptions

We’re pleased to announce today LegitScript’s newest certification program — one to certify the websites of dietary supplement sellers as a way for them to demonstrate credibility and regulatory compliance. Now, all US supplement manufacturers, resellers, and affiliates can apply through LegitScript to certify that their websites have been reviewed for problematic products, ingredients, and…

Continue Reading ›

“Alzheimer’s” on Track to Win LegitScript’s Infamous Yellow Flag Award for 2019

“Alzheimer’s” and related disease terms are on track to be this year’s top impermissible supplement marketing claim, which would earn it the LegitScript Yellow Flag Award for 2019. With four months still left in the year, will “Alzheimer’s” beat last year’s top impermissible claim — “inflammation” — or 2017’s winner, “cancer”? Only time and shady…

Continue Reading ›

Seizures Related to Vaping Highlight Risk of E-cigarette Merchants

The FDA said this week that it is investigating 127 incidents of people suffering from seizures after vaping. The news highlights the elevated risk e-cigarette products pose for legal violations, and why payment service providers should know about the many types of products and parts related to vaping to better monitor their portfolios.  The FDA’s…

Continue Reading ›

CBD Confusion in Iowa Highlights the Difficulty in Navigating Local CBD Laws

The Iowa Attorney General’s Office recently reminded Iowans that cannabidiol (CBD) is still considered a controlled substance in the state despite the newly passed Iowa Hemp Act, which legalized the production of hemp containing less than 0.3% THC. The confusion has resulted in enforcement efforts to stop its sale, and it illustrates a larger legal…

Continue Reading ›

The Top Marketing Claims CBD Merchants and Manufacturers Should Avoid

One of the aspects of cannabidiol (CBD) sales that can attract regulatory scrutiny is the way in which merchants market their CBD products. In the past five years, the FDA has sent many warning letters to manufacturers and merchants of CBD products for claims that their products can prevent, cure, mitigate, or treat diseases. No…

Continue Reading ›

LegitScript Announces New CBD Certification Program

We’re happy to announce a new certification program for legally compliant CBD products and websites. Starting today, US manufacturers and merchants can apply through LegitScript to certify CBD products and websites that are in compliance with USDA, FDA, FTC, and DEA regulations, as well as state-specific laws. LegitScript is the global leader in merchant and…

Continue Reading ›